Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 29 July 1994:
Vol. 265. no. 5172, pp. 648 - 651
DOI: 10.1126/science.8036512

Articles

Science, Vol 265, Issue 5172, 648-651
Copyright © 1994 by American Association for the Advancement of Science


articles

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

SW Rogers, PI Andrews, LC Gahring, T Whisenand, K Cauley, B Crain, TE Hughes, SF Heinemann, and JO McNamara

Salt Lake City Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center, UT.

Rasmussen's encephalitis is a progressive childhood disease of unknown cause characterized by severe epilepsy, hemiplegia, dementia, and inflammation of the brain. During efforts to raise antibodies to recombinant glutamate receptors (GluRs), behaviors typical of seizures and histopathologic features mimicking Rasmussen's encephalitis were found in two rabbits immunized with GluR3 protein. A correlation was found between the presence of Rasmussen's encephalitis and serum antibodies to GluR3 detected by protein immunoblot analysis and by immunoreactivity to transfected cells expressing GluR3. Repeated plasma exchanges in one seriously ill child transiently reduced serum titers of GluR3 antibodies, decreased seizure frequency, and improved neurologic function. Thus, GluR3 is an autoantigen in Rasmussen's encephalitis, and an autoimmune process may underlie this disease.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery.
N. Schwab, C. G. Bien, A. Waschbisch, A. Becker, G. H. Vince, K. Dornmair, and H. Wiendl (2009)
Brain 132, 1236-1246
   Abstract »    Full Text »    PDF »
Diagnostic and Pathogenic Significance of Glutamate Receptor Autoantibodies.
D. Pleasure (2008)
Arch Neurol 65, 589-592
   Abstract »    Full Text »    PDF »
Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis.
S. Matus, P. V. Burgos, M. Bravo-Zehnder, R. Kraft, O. H. Porras, P. Farias, L. F. Barros, F. Torrealba, L. Massardo, S. Jacobelli, et al. (2007)
J. Exp. Med. 204, 3221-3234
   Abstract »    Full Text »    PDF »
Chronic Myoclonia of Subcortical Origin With Antiglutamate Receptor Antibodies.
M. Matsuo, Y. Takahashi, K. Taniguchi, K. Sasaki, and Y. Hamasaki (2007)
J Child Neurol 22, 1393-1396
   Abstract »    PDF »
Treatment of Cystoid Macular Edema in Retinitis Pigmentosa With Intravitreal Triamcinolone.
L. Scorolli, M. Morara, A. Meduri, L. B. Reggiani, G. Ferreri, S. Z. Scalinci, and R. A. Meduri (2007)
Arch Ophthalmol 125, 759-764
   Abstract »    Full Text »    PDF »
TCR Activation Eliminates Glutamate Receptor GluR3 from the Cell Surface of Normal Human T Cells, via an Autocrine/Paracrine Granzyme B-Mediated Proteolytic Cleavage.
Y. Ganor, V. I. Teichberg, and M. Levite (2007)
J. Immunol. 178, 683-692
   Abstract »    Full Text »    PDF »
Acute Intermittent Porphyria, Rasmussen Encephalitis, or Both?.
B. Tziperman, B.-Z. Garty, N. Schoenfeld, V. Hoffer, N. Watemberg, D. Lev, Y. Ganor, M. Levite, and T. Lerman-Sagie (2007)
J Child Neurol 22, 99-105
   Abstract »    PDF »
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms..
F. Lang, C. Bohmer, M. Palmada, G. Seebohm, N. Strutz-Seebohm, and V. Vallon (2006)
Physiol Rev 86, 1151-1178
   Abstract »    Full Text »    PDF »
Neurologic autoantibodies: Cautious enthusiasm.
S. Vernino (2005)
Neurology 65, 1688-1689
   Full Text »    PDF »
Serum antibodies in epilepsy and seizure-associated disorders.
K. McKnight, Y. Jiang, Y. Hart, A. Cavey, S. Wroe, M. Blank, Y. Shoenfeld, A. Vincent, J. Palace, and B. Lang (2005)
Neurology 65, 1730-1736
   Abstract »    Full Text »    PDF »
{alpha}7-Acetylcholine receptor antibodies in two patients with Rasmussen encephalitis.
R. Watson, J.E.C. Jepson, I. Bermudez, S. Alexander, Y. Hart, K. McKnight, A. Roubertie, F. Fecto, J. Valmier, D. B. Sattelle, et al. (2005)
Neurology 65, 1802-1804
   Abstract »    Full Text »    PDF »
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement.
C. G. Bien, T. Granata, C. Antozzi, J. H. Cross, O. Dulac, M. Kurthen, H. Lassmann, R. Mantegazza, J.-G. Villemure, R. Spreafico, et al. (2005)
Brain 128, 454-471
   Abstract »    Full Text »    PDF »
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
R. Watson, Y. Jiang, I. Bermudez, L. Houlihan, L. Clover, K. McKnight, J. H. Cross, I. K. Hart, A. Roubertie, J. Valmier, et al. (2004)
Neurology 63, 43-50
   Abstract »    Full Text »    PDF »
An open study of tacrolimus therapy in Rasmussen encephalitis.
C. G. Bien, U. Gleissner, R. Sassen, G. Widman, H. Urbach, and C. E. Elger (2004)
Neurology 62, 2106-2109
   Abstract »    Full Text »    PDF »
Rasmussen Encephalitis.
R. P. Morse (2004)
Arch Neurol 61, 592-594
   Full Text »    PDF »
Rasmussen encephalitis with active inflammation and delayed seizures onset.
I. Korn-Lubetzki, C. G. Bien, J. Bauer, M. Gomori, H. Wiendl, L. Trajo, H. Ovadia, B. Wilken, V. H. Hans, C. E. Elger, et al. (2004)
Neurology 62, 984-986
   Abstract »    Full Text »    PDF »
A Murine Model for Neuropsychiatric Disorders Associated with Group A {beta}-Hemolytic Streptococcal Infection.
K. L. Hoffman, M. Hornig, K. Yaddanapudi, O. Jabado, and W. I. Lipkin (2004)
J. Neurosci. 24, 1780-1791
   Abstract »    Full Text »    PDF »
Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
O. Lily, J. Palace, and A. Vincent (2004)
Brain 127, 269-279
   Abstract »    Full Text »    PDF »
Experience with immunomodulatory treatments in Rasmussen's encephalitis.
T. Granata, L. Fusco, G. Gobbi, E. Freri, F. Ragona, G. Broggi, R. Mantegazza, L. Giordano, F. Villani, G. Capovilla, et al. (2003)
Neurology 61, 1807-1810
   Abstract »    Full Text »    PDF »
October 14 Highlights.
(2003)
Neurology 61, 875
   Full Text »    PDF »
Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua.
Y. Takahashi, H. Mori, M. Mishina, M. Watanabe, T. Fujiwara, J. Shimomura, H. Aiba, T. Miyajima, Y. Saito, A. Nezu, et al. (2003)
Neurology 61, 891-896
   Abstract »    Full Text »    PDF »
Human T Cells Express a Functional Ionotropic Glutamate Receptor GluR3, and Glutamate by Itself Triggers Integrin-Mediated Adhesion to Laminin and Fibronectin and Chemotactic Migration.
Y. Ganor, M. Besser, N. Ben-Zakay, T. Unger, and M. Levite (2003)
J. Immunol. 170, 4362-4372
   Abstract »    Full Text »    PDF »
Rasmussen's encephalitis: Early characteristics allow diagnosis.
T. Granata, G. Gobbi, R. Spreafico, F. Vigevano, G. Capovilla, F. Ragona, E. Freri, L. Chiapparini, P. Bernasconi, L. Giordano, et al. (2003)
Neurology 60, 422-425
   Abstract »    Full Text »    PDF »
Persistence of ictal activity after functional hemispherectomy in Rasmussen syndrome.
P. Thomas, B. Zifkin, G. Ghetau, and O. Delalande (2003)
Neurology 60, 140-142
   Abstract »    Full Text »    PDF »
The natural history of Rasmussen's encephalitis.
C. G. Bien, G. Widman, H. Urbach, R. Sassen, S. Kuczaty, O. D. Wiestler, J. Schramm, and C. E. Elger (2002)
Brain 125, 1751-1759
   Abstract »    Full Text »    PDF »
Intravenous immunoglobulin in neurological disease: a specialist review.
C M Wiles, P Brown, H Chapel, R Guerrini, R A C Hughes, T D Martin, P McCrone, J Newsom-Davis, J Palace, J H Rees, et al. (2002)
J. Neurol. Neurosurg. Psychiatry 72, 440-448
   Abstract »    Full Text »    PDF »
B cells and epilepsy: The odd couple.
J. O. McNamara (2002)
Neurology 58, 677-678
   Full Text »    PDF »
Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis.
S.E. Baranzini, K. Laxer, R. Saketkhoo, M.K. Elkins, J.M. Parent, R. Mantegazza, and J.R. Oksenberg (2002)
Neurology 58, 709-716
   Abstract »    Full Text »    PDF »
Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology.
C. G. Bien, H. Urbach, M. Deckert, J. Schramm, O. D. Wiestler, H. Lassmann, and C. E. Elger (2002)
Neurology 58, 250-257
   Abstract »    Full Text »    PDF »
Unihemispheric cerebral vasculitis mimicking Rasmussen's encephalitis.
C. Derry, R.C. Dale, M. Thom, D.H. Miller, and G. Giovannoni (2002)
Neurology 58, 327
   Full Text »    PDF »
Patterns of Cerebral Glucose Metabolism in Early and Late Stages of Rasmussen's Syndrome.
J. S. Lee, C. Juhasz, A. K. Kaddurah, and H. T. Chugani (2001)
J Child Neurol 16, 798-805
   Abstract »    PDF »
GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.
H. Wiendl, C. G. Bien, P. Bernasconi, B. Fleckenstein, C. E. Elger, J. Dichgans, R. Mantegazza, and A. Melms (2001)
Neurology 57, 1511-1514
   Abstract »    Full Text »    PDF »
18F-Fluorodeoxyglucose Positron Emission Tomography and MR Imaging Findings in Rasmussen Encephalitis.
D. J. Fiorella, J. M. Provenzale, R. Edward Coleman, B. J. Crain, and A. Al-Sugair (2001)
AJNR Am. J. Neuroradiol. 22, 1291-1299
   Abstract »    Full Text »    PDF »
Labeling of rat neurons by anti-GluR3 IgG from patients with Rasmussen encephalitis.
C. Frassoni, R. Spreafico, S. Franceschetti, N. Aurisano, P. Bernasconi, R. Garbelli, C. Antozzi, S. Taverna, T. Granata, and R. Mantegazza (2001)
Neurology 57, 324-327
   Abstract »    Full Text »    PDF »
Rasmussen Encephalitis Associated With Segmental Vitiligo of the Scalp: Clinicopathologic Report.
E. M. T. Yacubian, S. Rosemberg, T. L. Garrido Neto, S. K.N. Marie, R. M.F Valerio, and C. L. Jorge (2001)
J Child Neurol 16, 374-377
   Abstract »    PDF »
CNS involvement in systemic lupus erythematosus: a case with remarkable histopathological findings.
M J Rood, J F Haverman, S G van Duinen, F C Breedveld, J J G M Verschuuren, and T W J Huizinga (2001)
Ann Rheum Dis 60, 299-300
   Full Text »    PDF »
Cutting Edge: Granzyme B Proteolysis of a Neuronal Glutamate Receptor Generates an Autoantigen and Is Modulated by Glycosylation.
L. C. Gahring, N. G. Carlson, E. L. Meyer, and S. W. Rogers (2001)
J. Immunol. 166, 1433-1438
   Abstract »    Full Text »    PDF »
Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis.
F. Villani, R. Spreafico, L. Farina, A.R. Giovagnoli, P. Bernasconi, T. Granata, and G. Avanzini (2001)
Neurology 56, 248-250
   Abstract »    Full Text »    PDF »
Epilepsy: an autoimmune disease?.
J PALACE and B LANG (2000)
J. Neurol. Neurosurg. Psychiatry 69, 711-714
   Full Text »    PDF »
Epilepsy and the Immune System.
J. A. Aarli (2000)
Arch Neurol 57, 1689-1692
   Abstract »    Full Text »    PDF »
Proton Magnetic Resonance Spectroscopic Observations of Epilepsia Partialis Continua in Children.
Y. D. Park, J. D. Allison, K. L. Weiss, J. R. Smith, M. R. Lee, and D. W. King (2000)
J Child Neurol 15, 729-733
   Abstract »    PDF »
GluR3 Autoantibodies Destroy Neural Cells in a Complement-Dependent Manner Modulated by Complement Regulatory Proteins.
K. D. Whitney and J. O. McNamara (2000)
J. Neurosci. 20, 7307-7316
   Abstract »    Full Text »    PDF »
Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy.
J. Peltola, P. Kulmala, J. Isojarvi, A. Saiz, K. Latvala, J. Palmio, K. Savola, M. Knip, T. Keranen, and F. Graus (2000)
Neurology 55, 46-50
   Abstract »    Full Text »    PDF »
Status epilepticus with neuron-reactive serum antibodies: Response to plasma exchange.
M. Lousa, S. Sanchez-Alonso, R. Rodriguez-Diaz, and J. Dalmau (2000)
Neurology 54, 2163-2165
   Abstract »    Full Text »    PDF »
Nitric Oxide Redox Species Exert Differential Permeability Effects on the Blood-Brain Barrier.
K. M. K. Boje and S. S. Lakhman (2000)
J. Pharmacol. Exp. Ther. 293, 545-550
   Abstract »    Full Text »
An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and Epilepsy.
M. J. During, C. W. Symes, P. A. Lawlor, J. Lin, J. Dunning, H. L. Fitzsimons, D. Poulsen, P. Leone, R. Xu, B. L. Dicker, et al. (2000)
Science 287, 1453-1460
   Abstract »    Full Text »
Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate Receptor.
P. S. Smitt, A. Kinoshita, B. De Leeuw, W. Moll, M. Coesmans, D. Jaarsma, S. Henzen-Logmans, C. Vecht, C. De Zeeuw, N. Sekiyama, et al. (2000)
N. Engl. J. Med. 342, 21-27
   Full Text »    PDF »
Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis.
K. D. Whitney, P. I. Andrews, and J. O. McNamara (1999)
Neurology 53, 699
   Abstract »    Full Text »    PDF »
The Glutamate Receptor Ion Channels.
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis (1999)
Pharmacol. Rev. 51, 7-62
   Abstract »    Full Text »    PDF »
Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy.
J. P. Leach, D. W. Chadwick, J. B. Miles, and I. K. Hart (1999)
Neurology 52, 738
   Abstract »    Full Text »    PDF »
Molecular mimicry and immune-mediated diseases.
M. B. A. Oldstone (1998)
FASEB J 12, 1255-1265
   Abstract »    Full Text »
Autoimmunity to Glutamate Receptors in Rasmussen's Encephalitis: A Rare Finding or The Tip of an Iceberg?.
L. C. Gahring and S. W. Rogers (1998)
Neuroscientist 4, 373-379
   Abstract »    PDF »
B Lymphocytes Producing Demyelinating Autoantibodies: Development and Function in Gene-targeted Transgenic Mice.
T. Litzenburger, R. Fassler, J. Bauer, H. Lassmann, C. Linington, H. Wekerle, and A. Iglesias (1998)
J. Exp. Med. 188, 169-180
   Abstract »    Full Text »    PDF »
Celiac Disease Presenting as Gait Disturbance and Ataxia in Infancy.
J. S. Hahn, J. M. Sum, D. Bass, R. S. Crowley, and D. S. Horoupian (1998)
J Child Neurol 13, 351-353
   PDF »
Long-term selective IgG immunoadsorption improves Rasmussen's encephalitis.
C. Antozzi, T. Granata, N. Aurisano, G. Zardini, P. Confalonieri, G. Airaghi, R. Mantegazza, and R. Spreafico (1998)
Neurology 51, 302-305
   Abstract »    Full Text »    PDF »
Familial Alternating Epilepsia Partialis Continua With Chronic Encephalitis: Another Variant of Rasmussen Syndrome?.
K. Silver, F. Andermann, and K. Meagher-Villemure (1998)
Arch Neurol 55, 733-736
   Abstract »    Full Text »    PDF »
Pharmacological Characterization of the Human Ionotropic Glutamate Receptor Subtype GluR3 Stably Expressed in Mammalian Cells.
M. A. Varney, S. P. Rao, C. Jachec, C. Deal, S. D. Hess, L. P. Daggett, F.-F. Lin, E. C. Johnson, and G. Veliçelebi (1998)
J. Pharmacol. Exp. Ther. 285, 358-370
   Abstract »    Full Text »
Simple Partial Status Epilepticus and Antiglycolipid IgM Antibodies: Possible Epilepsy of Autoimmune Origin.
B. Guillon, E. de Ferron, J.-R. Feve, J. Honnorat, C. Caudie, B. Nogues, and P. Moreau (1997)
Arch Neurol 54, 1194-1196
   Abstract »    PDF »
Presence of Herpes Simplex DNA in Surgical Tissue From Human Epileptic Seizure Foci Detected by Polymerase Chain Reaction: Preliminary Study.
V. J. Sanders, S. L. Felisan, A. E. Waddell, A. J. Conrad, P. Schmid, B. E. Swartz, M. Kaufman, G. O. Walsh, A. A. F. De Salles, and W. W. Tourtellotte (1997)
Arch Neurol 54, 954-960
   Abstract »    PDF »
Identification of Amino Acids in the Glutamate Receptor, GluR3, Important for Antibody-binding and Receptor-specific Activation.
N. G. Carlson, L. C. Gahring, R. E. Twyman, and S. W. Rogers (1997)
J. Biol. Chem. 272, 11295-11301
   Abstract »    Full Text »    PDF »
Differential Expression of Glutamate Receptor Subtypes in Rat Pancreatic Islets.
C. D. Weaver, T. L. Yao, A. C. Powers, and T. A. Verdoorn (1996)
J. Biol. Chem. 271, 12977-12984
   Abstract »    Full Text »    PDF »
Case 7-1996- An eight-year-old boy with intractable seizures.
G.L. Holmes and M.P. Frosch (1996)
N. Engl. J. Med. 334, 586-593
   Full Text »    PDF »
Glutamate Receptor Autoimmunity in Rasmussen's Encephalitis.
J.O. McNamara, M. Patel, X.-P. He, S. Janumpalli, and K.D. Whitney (1996)
Cold Spring Harb Symp Quant Biol 61, 327-332
   Abstract »    PDF »
Motoneuron-Specific Expression of NR3B, a Novel NMDA-Type Glutamate Receptor Subunit That Works in a Dominant-Negative Manner.
M. Nishi, H. Hinds, H.-P. Lu, M. Kawata, and Y. Hayashi (2001)
J. Neurosci. 21, RC185
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)